Richtlijn CVRM feb2013 - KNMP

Hartst website c Hartstichting website. http://www.hartstichting.nl/hart_en_vaten/behandeling/
behandeling_vaten/aneurysma_behandeling/ geraadpleegd op 22-1-2013
Hartst 2009
Effect van leefstijlinterventies bij patiënten met hart- en vaatziekten of hoog risico, review.
Nederlandse Hartstichting, januari 2009.
Hartst 2012 Aneurysma van de buikaorta. Brochure: uitgave Nederlandse Hartstichting, versie 2.2, juni 2012
Hartst 2013 Hoog cholesterol. Brochure: uitgave Nederlandse Hartstichting, versie 2.9, januari 2013
Haugen 2009
Haugen BR. Drug that suppress TSH or cause central hypothyreoidism. Best pract res Clin
Endocrinol Metab 2009; 23: 793-800.
Hayward 2006 Hayward R, Hofer TP, Vijan S. Narrative review: lack of evidence for recommended lowdensity
lipoprotein treatment targets: a solvable problem. Ann Intern med 2006; 145: 520-30.
He 2004
He K, Song Y, Daviglus ML, Van Horn L, Dyer AR, Greenland P. Accumulated evidence on fish
consumption and coronary heart disease mortality: a meta-analysus of cohort studies.
Circulation 2004; 109: 2705-2711.
Heidenreich 1997 Heidenreich PA, Lee TT, Massie BM. Effect of beta-blockade on mortality in patients with heart
failure: a meta-analysis of randomized clinical trials. J Am Coll Cardiol 1997; 30: 27-34.
Henyan 2007 Henyan NN, Riche DM, East HE, Gann PN. Impact of statins on risk of stroke: a meta-analysis.
Ann Pharmacother 2007; 41 (12): 1937-1945.
Heran 2008
Heran BS, Wong MMY, Heran IK, Wright JM. Blood pressure lowering efficacy of angiotensin converting
enzyme (ACE) inhibitors for primary hypertension. Cochrane Database of Systematic Reviews 2008,
Issue 4. Art. No.: CD003823. DOI: 10.1002/14651858.CD003823.pub2
Hernandes 1998 Hernandes-Perera O, Perez-Sala D, Navarro-Antolin J, Sanchez-Pascuala R, Hernandez G, Diaz
C, et al. Effect of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin an
simvastatin, on the expression of endothelin-a and endothelial nitric oxide synthase in
vascular endothelial cells. J Clin Invest 1998; 101: 2711-2719.
Horning 2007 Horning KK, Hoehns JD, Doucette WR. Adherence to clinical practice guidelines for 7 chronic
conditions in long-term-care patients who received pharmacist disease management services
versus traditional drug regimen review. J Manag Care Pharm 2007;13: 28-36.
HPS 2002 Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol
lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled
Lancet 2002; 360: 7-22.
trial.
HPS 2011a Heart Protection Study Collaborative Group . Effects on 11-year mortality and morbidity of
lowering LDL cholesterol with simvastatin for about 5 years in 20 536 high-risk individuals: a
randomised controlled trial. The Lancet 2011; 378 (9808) : 2013 – 2020.
HPS 2011b Heart Protection Study Collaborative Group. C-reactieve protein concentration and the
vascular benefits of statin therapy: an analysis of 20536 patients in the Heart Protection
Study. The Lancet 2011; 9764 (377): 469-476.
Huang 2012 Huang B, Huang Y, Li Y, Yao H, Jing X, Hunag H, et al. Adverse cardiovascular effects of
concomittant use of proton pump inhibitors and clopidogrel in patients with coronary artery
disease: a systematic review and met analysis. Arch Med Res 2012; 43 (3): 212-24.
Huisman 2010 Huisman MV, Quinlan DJ, Dahl OE, Schulman S. Enoxaparin versus dabigatran or rivoroxaban
for thromboprophylaxis after hip of knee arhtroplasty: results of separate pooled analyses of
phase II multicenter randomized trials. Circ Cardiovasc Qual Outcomes 2010; 3 (6): 652-60.
Hurlen 2002
Hurlen M, Abdelnoor M, Smith P, Erikssen J, Arnesen H. Warfarin, aspirin, or both after myocardial
infarction. N Eng J Med 2002; 347: 969-74.
Jacobson 2008 Jacobson TA:Toward ‘pain-free’statin prescribing: clinical algorithm for diagnosis and
management of myalgia. Mayo Clin Proc 2008; 83: 687-700.
90
CONCEPT